Keyphrases
Chronic Kidney Disease
100%
Lipids
100%
Lipoproteins
100%
Atherosclerotic Cardiovascular Disease (ASCVD)
100%
Low-density Lipoprotein Cholesterol (LDL-C)
55%
Apolipoprotein A-I (ApoA-I)
33%
Apolipoprotein B (Apo B)
33%
High-density Lipoprotein Cholesterol (HDL-C)
22%
Low-density Lipoprotein Cholesterol Level
22%
Cardiovascular Disease Events
22%
Residual Risk
22%
Chronic Renal Insufficiency Cohort
22%
Myocardial Infarction
11%
United States
11%
Cholesterol
11%
Triglycerides
11%
Cox Proportional Hazards Regression
11%
Statins
11%
Ischemic Stroke
11%
Non-high-density Lipoprotein Cholesterol (non-HDL-C)
11%
Prospective Cohort Study
11%
Multivariable
11%
Pharmacologic
11%
Analytic Approach
11%
Cardiovascular Outcomes
11%
Myocardial Ischemia
11%
Triglyceride-rich Lipoproteins
11%
Low HDL-C
11%
Observational Data
11%
Atherosclerotic Cardiovascular Disease Risk
11%
Causal Association
11%
Non-dialysis Chronic Kidney Disease
11%
Biochemistry, Genetics and Molecular Biology
Lipid
100%
Apolipoprotein
100%
Artificial Intelligence
60%
Lipoprotein
60%
Very Low-Density Lipoprotein
60%
Apolipoprotein B
60%
Low Density Lipoprotein Cholesterol Level
40%
Low-Density Lipoprotein
40%
Cholesterol Blood Level
20%
Triglyceride
20%
Cohort Study
20%
Statin
20%
Triglyceride-Rich Lipoprotein
20%
Clinical Study
20%
Prospective Cohort Study
20%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Kidney Failure
100%
Coronary Artery Atherosclerosis
100%
Apolipoprotein
100%
Low Density Lipoprotein Cholesterol
30%
Lipoprotein
30%
Apolipoprotein B
30%
Very Low Density Lipoprotein Cholesterol
30%
Triacylglycerol
20%
Heart Infarction
10%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
10%
Cohort Study
10%
Brain Ischemia
10%
Prospective Cohort Study
10%
Clinical Study
10%
Medicine and Dentistry
Chronic Kidney Disease
100%
Apolipoprotein
100%
Low Density Lipoprotein Cholesterol
42%
Apolipoprotein B
42%
Very Low Density Lipoprotein Cholesterol
42%
Lipoprotein
28%
Myocardial Infarction
14%
Cohort Analysis
14%
Proportional Hazards Model
14%
Brain Ischemia
14%
Statin
14%
Triacylglycerol
14%
Prospective Cohort Study
14%
Clinical Study
14%
Triglyceride-Rich Lipoprotein
14%